In this month's Cancer News Review podcast, Cancer Center director Bill Nelson reviews top headlines in cancer research. Each of the studies discussed here were published in the Oct. 2 issue of the Lancet.
One of the most common complaints I hear from cancer survivors is a change in their sex life. Within days after returning home from my mastectomy, I attempted to be intimate with my husband even though I had yet to regain the ability to dress or shower myself with medical drains still attached. I thought […]
Oct 19, 2010 No comments
The final score was 3-0 last night at my son's soccer game -- his team won, but not because they have a single star that makes all the goals; rather, they worked together to make a collective effort in winning the game. The soccer community is now rallying their global fans and participants in a match against the […]
Oct 15, 2010 No comments
In a conversation with a patient recently, she said to me, “I am a mother and a wife, but when I think of what describes me most, it is that I am a cancer survivor. Having had cancer is the first thing I think about when I get up in the morning, the last thing I […]
Oct 12, 2010 No comments
Defining when a patient becomes a cancer “survivor” seems to vary depending on whom you ask. Some people say that this term can be applied after a patient has shown no evidence of disease for five years; others assert that survivor is a status achieved following the patient’s completion of all recommended treatments and surgeries. […]
Oct 7, 2010 1 comment
Of all the hard hat colors to choose from, you wouldn't think construction workers would opt to wear pink ones. But that's just what they did at Johns Hopkins to honor breast cancer awareness month. Construction employees of EMCOR Group, Inc., a mechanical and electrical construction company, who are working at Hopkins on what is believed to be the largest hospital […]
Oct 5, 2010 1 comment
It was the culmination of years of effort by many scientists and physicians and the bravery of patients to try something new that has brought some steady hope in an experimental therapy called epigenetics.
Oct 1, 2010 No comments